PuriCore PLC (LSE:PURI) - Overview

Stock Report

PuriCore PLC PURI

Last Price
GBX29.75

Day Change
0.00|0.00%

As of 02/12/2016
14:35:13 GMT | GBX
Minimum 15 Minutes Delay.

Last Close29.75p
Day Range28.88 - 30.25
Mkt Cap14.92Mil
52-Wk Range16.90 - 31.40
Yield %0.00
ISINGB00B3XBCR18
Volume1,515
P/E-2.74
P/S0.94
P/CF-6.42

Share Price

Total Returns 02/12/2016

 Chg (%)  
More ...
PuriCore PLC-0.83 
FTSE 100 TR GBP-1.21
 
Financials
201320142015
More ...
Income Statement
Turnover20.2110.4315.80
Operating Profit-1.84-4.49-6.51
Net Profit-5.54-4.27-6.33
Reported EPS-11.56-8.52-12.83
Balance Sheet
Current Assets8.2815.9813.67
Non Current Assets7.534.313.06
Total Assets15.8120.2916.73
Current Liabilities7.752.073.68
Total Liabilities7.752.073.68
Total Equity8.0518.2213.05
Cash Flow
Operating Cash Flow0.69-1.64-2.53
Net Change in Cash0.6310.63-3.64
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
22/09/2016PurchaseMr. Charles Spicer28.8717,3195,000.00
22/09/2016PurchaseMr. Charles Spicer28.6017,4825,000.00
29/03/2016PurchaseMr. Alex Martin28.00100,00028,000.00

Company Profile

PuriCore PLC a specialty biopharmaceutical company focused on developing novel immunomodulatory therapies, based on its proprietary hypochlorous acid platform technology.
 

Sector

Biotechnology

Market Position

1402 of 1865 Companies

Index

Outlook

(20/09/2016) no outlook statement

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)0.0017.2116.27
Div Yld (E)0.002.024.36
PEG (E)0.001.490.00
ROCE-42.0333.3680.66
Op Mrgn-35.01-26.17-14.86
EPS Grwth0.0015.6125.03
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Charles Spicer
Chief Executive OfficerMr. Alex Martin
Grp Fin Dir, Com Sec & Chf Opp OffcrMarella Thorell
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.